Your feature on the introduction of the Alzheimer's drug, donepezil, in the Withington Hospital, Manchester, ('Making introductions', pages 28-29, 25 February) stated that 'evidence of its efficacy in clinical use and its cost-effectiveness can only be obtained from further research and audit after its introduction in clinical practice'.